India's $30B Pharma Exports: Shift to Non-Animal Drug Testing (NAMs) Key to Innovation

Proposed Patient Data Collective (PDC) Model for Rare Diseases in India Inspired by Amul Cooperative

A new proposal suggests creating a Patient Data Collective (PDC) for rare diseases in India, modeled on the Amul dairy cooperative. This collective would pool patient data to accelerate drug discovery and clinical trials, addressing the challenge of small patient populations for rare diseases.

Stem Cell Therapy for Autism Restricted to Clinical Trials; Health Ministry Advisory Follows SC Order

The Union Health Ministry has reiterated that stem cell therapy for Autism Spectrum Disorder (ASD) can only be offered as part of approved clinical trials, not as routine or commercial treatment. This follows a landmark Supreme Court judgment in January 2026 that examined the issue. The advisory reinforces existing regulations under the Clinical Establishments Act, 2010, and the National Guidelines for Stem Cell Research, 2017.

SC Applies Section 498A to Live-in Relationships; NOTTO Launches Real-Time Organ Transplant Portal with Aadhaar Pledges

The Indian Express UPSC Key for August 4, 2026, covers multiple crucial topics: the Supreme Court's ruling extending Section 498A cruelty protection to live-in relationships, the launch of a real-time organ transplant portal by NOTTO, the Vikram Sarabhai Medal awarded to Annapurni Subramaniam, India's resilient fertiliser supply amid the Iran war, the science behind Europe's wildfires, and the Ceuta migrant crisis. These topics span Polity, Health, Science, Environment, and International Relations, offering direct material for UPSC Prelims and Mains.

Anil Kakodkar Advocates Early Thorium Shift in PHWR Fleet for India’s 100 GWe Nuclear Mission by 2047

India's top nuclear scientist Anil Kakodkar urges early introduction of thorium-based fuel in India's indigenous PHWR fleet to accelerate utilisation of the world's largest thorium reserves. This strategic shift, using HALEU-thorium fuel without major design changes, aims to reduce uranium import dependency and achieve the 100 GWe nuclear mission by 2047.

India's R&D Spending, Patents Surge but Systemic Barriers Hinder Science Superpower Status: E-book

A Hindu e-book analyzes India's scientific trajectory, noting increased R&D spending and patent filings but flagging critical gaps: poor lab-to-market translation, bureaucratic hurdles, brain drain, and rising pseudoscience. For exams, this is a rich source of 'Challenges to India's Innovation Ecosystem' for GS3.

India Gets First Disease-Modifying Alzheimer's Drug Leqembi After CDSCO Nod

Eisai's Leqembi (lecanemab), India's first disease-modifying therapy for early Alzheimer's, has been launched after CDSCO approval. This marks a shift from symptomatic to disease-modifying treatment, but challenges of early diagnosis, biomarker infrastructure, and affordability remain significant.

$10 Bn AI Investment Can Bring India to AI Frontier in 1 Year: Sarvam AI CEO

India's AI gap with the global frontier is just $10 billion, and with targeted investment, the country can catch up within a year, according to Sarvam AI CEO Pratyush Kumar. The India AI Impact Summit in February saw over $400 billion in AI capex commitments, and voice AI is emerging as India's first billion-dollar revenue opportunity. However, job creation and upskilling remain critical challenges.

TN Budget 2026-27: India's First AI City 'Arivagam' & Space Industrial Zone with ₹35,062 Cr MoUs

Tamil Nadu's TVK-led government, in its maiden Budget for 2026-27, announced India's first AI and innovation city 'Arivagam', a Space Industrial Investment Zone in Thoothukudi and Tirunelveli, and signed MoUs worth ₹35,062 crore that could create 14,790 jobs. This signals a major push for technology and industrial growth in the state.